KR

INTELLECTUAL PROPERTY

  • R&D
  • INTELLECTUAL PROPERTY

INTELLECTUAL PROPERTY

Patent Application 25

Patent Registration 86

Title of Invention Domestic
Application Number
Domestic
Registration Number
PCT
Application Number
Heteroarylamidopyridinol derivatives and pharmaceutical composition for use in preventing or treating autoimmune diseases containing the same as an active ingredient 10-2019-0117253 10-2426921 PCT/KR2020/013003
WO 2021/060890
Pharmaceutical composition for preventing or treating keloid or hypertrophic scar comprising Benzbromarone 10-2021-0044713 10-2404883 PCT/KR2021/017723
WO 2022/114881
Novel benzofuranyl hydroxyphenyl methanone derivative compounds or pharmaceutically acceptable salts thereof 10-2022-0127758 10-2684807 PCT/KR2022/015097
WO 2023/059121
Novel isoindolinone derivative compounds as caspase inhibitors 10-2022-0075801 10-2670554 PCT/KR2023/000101
WO 2023/132606
Benzofuranyl hydroxyphenyl methanone oxime derivative and the use thereof 10-2022-0063202 10-2782945 PCT/KR2022/010099
WO 2023/229099
Novel heterocyclic compounds 10-2024-0000388 10-2727682 PCT/KR2024/000042
WO 2024/154979
Novel pyrazole derivative and the use thereof 10-2024-0087101 10-2791027 PCT/KR2024/009316
WO 2025/009852
  • Headquater T. +82(2)-6956-8680
  • R&D T. +82(42)-721-0012
  • E. contact@innovothera.com

Innovo Therapeutics Inc.

  • Headquater : 507, 38 Mapo-daero, Mapo-gu, Seoul, 04174, Korea
  • CEO : HeeDong Park
  • Business registration number : 379-86-01520
  • R&D : C-313, 17 Techno 4-ro, Yuseong-gu, Daejeon, 34013, Korea

Copyright © 2022 innovotherapeutics All rights reserved.